Landos Biopharma to Be Acquired by AbbVie
Cooley advised Landos Biopharma, a clinical-stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune diseases, on its definitive agreement under which it will be acquired by AbbVie. Landos Biopharma to Be Acquired by AbbVie
Nuvation Bio to Acquire AnHeart Therapeutics
Cooley advised Nuvation Bio (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, on its definitive agreement to acquire AnHeart Therapeutics, a global clinical-stage biopharmaceutical company developing precision therapies for people with cancer. Nuvation Bio to Acquire AnHeart […]
Rubicon Technology Partners Announces Investment in Ascend Analytics
Cooley advised Rubicon Technology Partners, a private equity firm based in Boulder, Colorado, focused exclusively on investing in and growing software companies, on its strategic growth investment in Ascend Analytics. Rubicon Technology Partners Announces Investment in Ascend Analytics
Sazerac Agrees to Acquire BuzzBallz
Cooley advised Sazerac, one of the world’s largest distilled spirits companies, on its agreement to acquire BuzzBallz, a woman-owned and family-operated distillery, winery and brewery in Texas. Sazerac Agrees to Acquire BuzzBallz
Amolyt Pharma Agrees to Be Acquired by AstraZeneca in up to $1.05 Billion Cross-Border Transaction
Cooley advised Amolyt Pharma, a global clinical-stage biopharmaceutical company based in Lyon, France, that specializes in developing therapeutic peptides for rare endocrine and related diseases, on its definitive agreement to be acquired by AstraZeneca for up to $1.05 billion in cash. Amolyt Pharma Agrees to Be Acquired by AstraZeneca in […]
JMI Equity Sells Incident IQ to Cove Hill Partners
Cooley advised JMI Equity, a growth equity firm focused on investing in top software companies, on the sale of Incident IQ to Cove Hill Partners. JMI Equity Sells Incident IQ to Cove Hill Partners
HiredScore to Be Acquired by Workday
Cooley advised HiredScore, which provides artificial intelligence-powered talent orchestration solutions, on its acquisition by Workday (NASDAQ: WDAY), a provider of solutions to help organizations manage their people and money. HiredScore to Be Acquired by Workday
Jackpocket Reaches Agreement to Be Acquired by DraftKings for $750 Million
Cooley advised Jackpocket, the first licensed third-party lottery courier app in the US, on its definitive agreement to be acquired by DraftKings (Nasdaq: DKNG) for $750 million. Jackpocket Reaches Agreement to Be Acquired by DraftKings for $750 Million
Everbridge Enters Into Definitive Agreement to Be Acquired by Thoma Bravo for $1.5 Billion
Cooley advised Everbridge (listed as EVBG on Nasdaq), a global leader in critical event management and national public warning solutions, on its definitive agreement to be acquired by Thoma Bravo in an all-cash transaction valuing Everbridge at approximately $1.5 billion. Everbridge Enters Into Definitive Agreement to Be Acquired by Thoma […]
Tectonic Therapeutic Announces Merger With AVROBIO, $130.7 Million Private Financing Commitments
Cooley advised Tectonic Therapeutic, a privately held biotechnology company developing G-protein coupled receptor-targeted therapeutic proteins, on its definitive merger agreement to combine in an all-stock transaction with AVROBIO, a gene therapy company with a purpose to free people from a lifetime of genetic disease. Tectonic Therapeutic Announces Merger With AVROBIO, […]